Enjoy complimentary customisation on priority with our Enterprise License!
The global hemodialysis and peritoneal dialysis market size is estimated to grow by USD 6.61 billion at a CAGR of 5.97% between 2023 and 2028. The growing geriatric population notably drives market growth. Chronic diseases like CKD prevail among the elderly. Aging correlates with susceptibility to infections due to weakened immune systems. Reduced organ function also increases CKD risk. Aging drives healthcare spending, including disease diagnosis and treatment. According to the UN, those aged 80 or above will triple by 2050. Home-based dialysis demand rises, driven by patient-centric care and treatment flexibility. Improved lifestyle and convenience reduce the need for frequent dialysis center visits, enhancing overall quality of life. Wearable devices and renal replacement therapies offer autonomy, benefiting patients and reducing mortality rates. Organ donors play a vital role in acute kidney injury (AKI) and acute kidney disease treatment. Risks and complications include cardiac diseases and vascular access-related issues.
To learn more about this report, Download Report Sample
The market share growth by the devices segment will be significant during the forecast period. This segment plays a pivotal role in providing the necessary tools for procedures, encompassing machines, catheters, tubing sets, and associated accessories, as well as technological innovations aimed at enhancing treatment efficacy, patient safety, and the overall dialysis experience.
Get a glance at the market contribution of various segments Download PDF Sample
The devices segment was the largest and was valued at USD 10.39 billion in 2018. Notable advancements in peritoneal dialysis devices include the development of low-resistance catheters, automated cyclers, and remote patient monitoring systems aimed at optimizing treatment outcomes, reducing the risk of complications, and enhancing patient autonomy. For instance, the integration of telemedicine platforms with peritoneal dialysis devices has enabled remote monitoring of patients, real-time intervention, and personalized care delivery, thus exemplifying the technological progress within this segment. Thus, the above-mentioned advantages are expected to increase the adoption of devices, which will drive the growth of the devices segment of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In addition, the US and Canada accounted for the largest market shares in the region in the same year. The growth of the market in North America can be attributed to the high prevalence of CKD in the region, the existence of advanced healthcare infrastructure, and the strong market presence of the leading vendors. According to the data published by the Centers for Disease Control and Prevention (CDC), in 2020, approximately 130,522 people initiated treatment for end-stage kidney disease (ESKD) in the US.
Additionally, even though CKD occurs among people of all age groups, it is more prevalent among those who are aged 65 years and above. In 2021, more than one in seven, i.e., 15% of the US adult population or 37 million people, had CKD. These statistics underscore the significant impact of end-stage kidney disease on a substantial portion of the US population and highlight the need for treatment modalities such as kidney transplantation and dialysis in managing this serious health issue. Thus, the increasing prevalence of CKD will propel the adoption of devices and consumables, which will drive the growth of the regional market during the forecast period.
The Hemodialysis and Peritoneal Dialysis Market is witnessing significant growth driven by the growing geriatric population, leading to an increase in the prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD). A notable trend in this market is the growing demand for home-based dialysis treatments, such as Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis (APD), providing patients with greater accessibility and flexibility in managing their conditions.
However, a significant challenge facing the industry is the shortage of skilled professionals, including dialysis service providers and organ donors, which impacts the accessibility of dialysis treatment and kidney transplants. Despite technological advancements in renal replacement therapies and wearable devices, vascular access problems/vascular access-related complications, such as peritonitis and cardiac diseases, remain significant risks for patients undergoing dialysis, emphasizing the importance of healthcare infrastructure and stringent monitoring protocols to reduce mortality rates and improve patient outcomes. As healthcare expenditure and reimbursement policies evolve to address the growing burden of renal disease, collaboration between healthcare providers and organizations like the National Kidney Foundation is essential in advancing dialysis treatment and enhancing patient care.
The growing geriatric population is notably driving the market growth. The prevalence of chronic diseases, such as CKD, is high among the aging population. There is a direct relationship between aging and susceptibility to infections, as the immune system deteriorates with age. Apart from the impaired functioning of the immune system, the reduced functioning of organs also increases the chances of acquiring diseases such as CKD. The rise in the aging population has increased expenditure on healthcare, disease diagnosis, and treatment. For instance, according to the United Nations, the number of persons aged 80 years or above is projected to triple, from 143 million in 2019 to 426 million in 2050.
Moreover, the common health problems affecting older adults such as CKD, acute renal failure, and others. The elderly population requires regularly due to their low immunity and metabolism. Hence, the increasing aging population will increase the number of devices and consumables, which will subsequently augment the growth of the market during the forecast period.
Growing demand for home-based dialysis treatments is an emerging trend shaping the market growth. The market is experiencing a surge in demand for home-based dialysis treatments, driven by factors promoting patient-centric care and enhanced treatment flexibility. Improved convenience and lifestyle flexibility are primary drivers, offering patients the ability to receive care in their homes and reducing the need for frequent dialysis center visits. This autonomy enhances the overall quality of life, fostering empowerment and independence.
Supportive healthcare policies and reimbursement frameworks further contribute to the growth of home-based dialysis programs, anticipating increased demand in the global market. Such factors are expected to fuel the market growth during the market forecast period.
A shortage of skilled professionals is a significant challenge hindering the market growth. Amid the rapidly rising rates of CKD and its risk factors, such as diabetes and hypertension, the global nephrology workforce has shrunk and failed to expand to meet the growing healthcare needs of this vulnerable patient population. There is an acute shortage of dialysis nurses, technicians, nephrology trainees, and nephrologists in many parts of the world, both in low-income and high-income countries, such as the US, Australia, New Zealand, China, India, and various European countries. The shortage of nephrologists and nephrology technicians is particularly acute in low-income countries.
Additionally, several national and international professional organizations and expert groups on workforce planning predict further reductions in the global nephrology workforce over the next decade, which will have potentially serious implications. The delivery of care to patients with CKD may be threatened in several countries across the world unless effective country-specific workforce strategies are put in place and implemented. Such factors will hinder market growth and trends during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
3M Co. - The company offers products such as 3M MEMBRANA PUREMA, 3M MEMBRANA DIAPES, and 3M MEMBRANA SYNPHAN.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The Hemodialysis and Peritoneal Dialysis Market has witnessed significant advancements propelled by technology advancements and rising cases of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD). While kidney transplants remain the gold standard, many individuals rely on dialysis due to a shortage of donors or medical ineligibility. Both FDA regulations and guidelines set by the World Health Organization ensure the safety and efficacy of dialysis products and practices.
In hemodialysis, options like conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis sessions offer more frequent treatment, enhancing patient outcomes. Conversely, Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis (APD) provide flexibility and independence for those opting for peritoneal dialysis.
Despite technological strides, patients encounter challenges like vascular access issues and complications such as peritonitis, alongside comorbidities like heart illnesses and pneumonia.
Efforts by organizations like the National Kidney Foundation, alongside government initiatives, aim to improve accessibility to dialysis treatments. Additionally, initiatives addressing healthcare expenditure and reimbursement policies strive to ease financial burdens on dialysis patients.
Innovations like the Tablo® mobile hemodialyzer and Phozevel Tablets offer promising solutions, while continued research and development promise further improvements in dialysis care.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028
Market Scope |
|
Report Coverage |
Details |
Page number |
173 |
Base year |
2023 |
Historic period |
2018-2022 |
Market forecasting period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.97% |
Market Growth 2024-2028 |
USD 6.61 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.53 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Allmed Medical Care Holdings Ltd., AngioDynamics Inc., ANGIPLAST Pvt. Ltd., Asahi Kasei Corp., Atlantic Biomedical Pvt. Ltd., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Boston Scientific Corp., Dialife SA, Fresenius SE and Co. KGaA, JMS Co. Ltd., Medical Components Inc., Medtronic Plc, Mitra Industries Pvt. Ltd., Nikkiso Co. Ltd., Nipro Medical Corp., Outset Medical Inc., Rockwell Medical Inc., Toray Industries Inc., V J Industries, and AWAK Technologies |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research and growth report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.